Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Sullivan

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Investigational New Drugs|January 3, 2021
Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancersJ Wu, D Liu, M Offin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumabA M Menzies, D B Johnson, S Ramanujam, et al.
Science (New York, N.Y.)|December 4, 2004
Localization and physical property experiments conducted by Opportunity at Meridiani PlanumR E Arvidson, R C Anderson, P Bartlett, et al.
Science (New York, N.Y.)|August 7, 2004
Wind-related processes detected by the Spirit Rover at Gusev Crater, MarsR Greeley, S W Squyres, R E Arvidson, et al.
Science (New York, N.Y.)|August 7, 2004
Localization and physical properties experiments conducted by Spirit at Gusev CraterR E Arvidson, R C Anderson, P Bartlett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2026
Five-Year Survival with Tebentafusp in Metastatic Uveal MelanomaS Piperno-Neumann, P Rutkowski, J C Hassel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2021
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanomaC N Owen, X Bai, T Quah, et al.
Science (New York, N.Y.)|May 23, 2009
Exploration of Victoria crater by the Mars rover OpportunityS W Squyres, A H Knoll, R E Arvidson, et al.
Science (New York, N.Y.)|December 4, 2004
Pancam multispectral imaging results from the Opportunity Rover at Meridiani PlanumJ F Bell, S W Squyres, R E Arvidson, et al.
Science (New York, N.Y.)|August 7, 2004
Pancam multispectral imaging results from the Spirit Rover at Gusev CraterJ F Bell, S W Squyres, R E Arvidson, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Investigational New Drugs|January 3, 2021
Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancersJ Wu, D Liu, M Offin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumabA M Menzies, D B Johnson, S Ramanujam, et al.
Science (New York, N.Y.)|December 4, 2004
Localization and physical property experiments conducted by Opportunity at Meridiani PlanumR E Arvidson, R C Anderson, P Bartlett, et al.
Science (New York, N.Y.)|August 7, 2004
Wind-related processes detected by the Spirit Rover at Gusev Crater, MarsR Greeley, S W Squyres, R E Arvidson, et al.
Science (New York, N.Y.)|August 7, 2004
Localization and physical properties experiments conducted by Spirit at Gusev CraterR E Arvidson, R C Anderson, P Bartlett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2026
Five-Year Survival with Tebentafusp in Metastatic Uveal MelanomaS Piperno-Neumann, P Rutkowski, J C Hassel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2021
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanomaC N Owen, X Bai, T Quah, et al.
Science (New York, N.Y.)|May 23, 2009
Exploration of Victoria crater by the Mars rover OpportunityS W Squyres, A H Knoll, R E Arvidson, et al.
Science (New York, N.Y.)|December 4, 2004
Pancam multispectral imaging results from the Opportunity Rover at Meridiani PlanumJ F Bell, S W Squyres, R E Arvidson, et al.
Science (New York, N.Y.)|August 7, 2004
Pancam multispectral imaging results from the Spirit Rover at Gusev CraterJ F Bell, S W Squyres, R E Arvidson, et al.
Pageof 10